lamivudine has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, MW; Yeh, CT | 1 |
| Ashman, C; Belmonte, AR; Cammack, N; Hooker, EU; Jin, H; Mansour, TS; Salomon, H; Wainberg, MA; Wang, W | 1 |
2 other study(ies) available for lamivudine and Experimental Hepatoma
| Article | Year |
|---|---|
The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant.
Topics: Adult; Animals; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; NIH 3T3 Cells; Taiwan; Transcriptional Activation | 2008 |
Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.
Topics: Animals; Antiviral Agents; Deoxycytidine; Hepatitis B virus; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Liver Neoplasms, Experimental; Stereoisomerism; Thionucleosides; Zalcitabine | 1995 |